# DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

> **NCT03387462** · PHASE4 · COMPLETED · sponsor: **Public Health Foundation Enterprises, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Adherence, Medication
- Risk Behavior
- Pre-Exposure Prophylaxis
- HIV Prevention

## Interventions

- **DRUG:** Emtricitabine / Tenofovir Disoproxil Oral Tablet
- **OTHER:** DOT Diary mobile app

## Key facts

- **NCT ID:** NCT03387462
- **Lead sponsor:** Public Health Foundation Enterprises, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-28
- **Primary completion:** 2018-08-30
- **Final completion:** 2018-08-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03387462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03387462, "DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03387462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*